Healthcare ❯ Pharmaceuticals

Weight Loss Drugs

Ozempic Semaglutide GLP-1 Drugs Wegovy Mounjaro GLP-1 Agonists Novo Nordisk GLP-1 Medications Zepbound Tirzepatide Clinical Trials GLP-1s GLP-1 Treatments GLP-1 Receptor Agonists Tirzepatide (Zepbound) Challenges Approval and Availability Financial Barriers Cost Reduction and Access Eli Lilly Regulation Market Competition Regulatory Issues GLP-1 Petrelintide Side Effects Tirzepatide vs. Semaglutide Comparison Clinical Studies Market Availability Market Trends Cost Barriers Effectiveness Studies Prescription Medications GLP Inhibitors Insurance Coverage Obesity Treatments Incretin Drugs Survodutide Amycretin

Mounjaro Price Rise Drives Up Out-of-Pocket Costs for UK Users

Private buyers now face about £319 a month, prompting providers to suggest Wegovy as a lower-cost option.

Lilly’s Oral GLP-1 Pill Meets Phase 3 Goals, Shares Rebound

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment

UK Regulators Warn Weight-Loss Injections Could Undermine Birth Control

Delhi High Court Bars Dr. Reddy’s and OneSource from Marketing Semaglutide

Novo Nordisk CEO Steps Down Following Share Price Collapse

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Hims & Hers Expands Weight-Loss Offerings with New Medications

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

U.S. Obesity Rates Decline for First Time in Over a Decade

Expanded Access to Weight-Loss Drugs Could Save Over 40,000 Lives Annually

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Ozempic Shows Promise Beyond Diabetes Treatment

Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic in Weight Loss Study

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

Zealand Pharma's Petrelintide Shows Promising Results in Early Weight Loss Trial